By searching SCP, we further verified that TGFBI mainly residents in malignant cell and putative tumor cells, it also showed that patients who received TKI treatment had lower TGFBI level, however, when comparing its profiles in ICB responders and ICB non responders, there was no notable difference. This evidence concerns the gene TGFBI and neoplasm.